Mesenchymal stem cells in allergic diseases: Current status
Allergic diseases, which include asthma, allergic skin diseases, allergic rhinitis and allergic conjunctivitis, have already garnered worldwide public health attention over recent decades. Mesenchymal stem cells (MSCs) have gradually emerged as a potential method for treating allergic diseases due t...
Main Authors: | He Li, Yunzhe Tian, Lihui Xie, Xiuxing Liu, Zhaohao Huang, Wenru Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Allergology International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S132389301930111X |
Similar Items
-
IL-38: A New Player in Inflammatory Autoimmune Disorders
by: Lihui Xie, et al.
Published: (2019-08-01) -
Pharmacological Inhibition of Caspase-8 Suppresses Inflammation-Induced Angiogenesis in the Cornea
by: Yunzhe Tian, et al.
Published: (2020-01-01) -
The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
by: Shizhao Yang, et al.
Published: (2021-06-01) -
Mesenchymal Stem Cell-Based Therapy for Allergic Rhinitis
by: Liwei Sun, et al.
Published: (2020-01-01) -
Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges
by: Xueke Zhou, et al.
Published: (2020-06-01)